Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription 21.08.2023 1 Ann Intern Med 1 Antiviral Res 2 Arch Virol 1 BMC Pediatr 5 BMJ 1 Epidemiol Infect 2 Eur J Epidemiol 1 J Epidemiol Community Health 1 J Infect 13 J Infect Dis 6 JAMA 2 Lancet 3 MMWR Morb Mortal Wkly Rep 1 PLoS Comput Biol 37 PLoS One 5 Proc Natl Acad Sci U S A 9 Vaccine 1 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. DELOUGHERY TG
   In noncritical COVID-19, therapeutic vs. prophylactic anticoagulation did not reduce a composite adverse clinical outcome at 30 d.
   Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0059.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. IVASHCHENKO AA, Jones JC, Shkil DO, Ivanenkov YA, et al
   Resistance profiles for the investigational neuraminidase inhibitor AV5080 in influenza A and B viruses.
   Antiviral Res. 2023;217:105701.
   PubMed         Abstract available
   
   

   
   Arch Virol

3. PHAM NTK, Khamrin P, Shimizu-Onda Y, Hoque SA, et al
   Genetic diversity and declining norovirus prevalence in infants and children during Japan's COVID-19 pandemic: a three-year molecular surveillance.
   Arch Virol. 2023;168:231.
   PubMed         Abstract available
   
   
4. MA H, Ren S, Meng Q, Su B, et al
   Role of Tim-3 in COVID-19: a potential biomarker and therapeutic target.
   Arch Virol. 2023;168:213.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

5. CHALERMCHUTIDEJ W, Manaboriboon B, Sanpawitayakul G, Theppiban S, et al
   Sleep, social media use and mental health in female adolescents aged 12 to 18 years old during the COVID-19 pandemic.
   BMC Pediatr. 2023;23:398.
   PubMed         Abstract available
   
   

   
   BMJ

6. LANG K
   How do we best use Paxlovid and other covid antivirals?
   BMJ. 2023;382:p1666.
   PubMed        
   
   
7. DYER O
   Covid-19: Infections climb globally as EG.5 variant gains ground.
   BMJ. 2023;382:p1900.
   PubMed        
   
   
8. PAGEL C
   Covid is on the rise again-so what next?
   BMJ. 2023;382:p1885.
   PubMed        
   
   
9. IACOBUCCI G
   Covid-19: A year is too long to wait for UK inquiry's recommendations, say bereaved families.
   BMJ. 2023;382:1853.
   PubMed        
   
   
10. OSERAN AS, Song Y, Xu J, Dahabreh IJ, et al
    Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study.
    BMJ. 2023;382:e076222.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

11. GUO Y, Zeng X, Li L, Wang L, et al
    The impact of HBV infection on clinical outcomes of COVID-19 patients: a systematic review and meta-analysis.
    Epidemiol Infect. 2023;151:e135.
    PubMed         Abstract available
    
    

    
    Eur J Epidemiol

12. LIN S, Gao X, Degenhardt F, Qian Y, et al
    Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.
    Eur J Epidemiol. 2023;38:883-889.
    PubMed         Abstract available
    
    
13. NORREDAM M, Islamoska S, Petersen JH, Benfield T, et al
    COVID-19 mortality and use of intensive care among ethnic minorities - a national register-based Danish population study.
    Eur J Epidemiol. 2023;38:891-899.
    PubMed         Abstract available
    
    

    
    J Epidemiol Community Health

14. OHNO M, Dzurova D, Smejkal P
    Health inequalities in post-COVID-19 outcomes among adults aged 50+ in Europe: has COVID-19 exposed divide between postcommunist countries and Western Europe?
    J Epidemiol Community Health. 2023;77:601-608.
    PubMed         Abstract available
    
    

    
    J Infect

15. WAGENHAUSER I, Mees J, Reusch J, Lam TT, et al
    Determinants of Influenza A Infection Rate in Post-COVID-19 Era.
    J Infect. 2023 Aug 9:S0163-4453(23)00455-3. doi: 10.1016/j.jinf.2023.
    PubMed        
    
    

    
    J Infect Dis

16. BEBIA Z, Reyes O, Jeanfreau R, Kantele A, et al
    Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: a phase 2 randomized trial.
    J Infect Dis. 2023 Feb 1:jiad024. doi: 10.1093.
    PubMed         Abstract available
    
    
17. ROWLEY AH, Arrollo D, Shulman ST, Torres A, et al
    Analysis of Plasmablasts From Children With Kawasaki Disease Reveals Evidence of a Convergent Antibody Response to a Specific Protein Epitope.
    J Infect Dis. 2023;228:412-421.
    PubMed         Abstract available
    
    
18. DIMCHEFF DE, Blair CN, Zhu Y, Chappell JD, et al
    Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
    J Infect Dis. 2023;228:235-244.
    PubMed         Abstract available
    
    
19. ANDEREGG N, Schwab T, Borcard L, Mugglin C, et al
    Population-Based Severe Acute Respiratory Syndrome Coronavirus 2 Whole-Genome Sequencing and Contact Tracing During the Coronavirus Disease 2019 Pandemic in Switzerland.
    J Infect Dis. 2023;228:251-260.
    PubMed         Abstract available
    
    
20. NURMI V, Knight C, Estcourt L, Hepojoki J, et al
    The relationship between SARS-CoV-2 neutralising antibody titres and avidity in plasma collected from convalescent non-vaccinated and vaccinated blood donors.
    J Infect Dis. 2023 Mar 27:jiad070. doi: 10.1093.
    PubMed         Abstract available
    
    
21. TANG L, Wang FZ, Rodewald LE, Wang XY, et al
    Real-world effectiveness of primary series and booster doses of inactivated COVID-19 vaccine against Omicron BA.2 variant infection in China: a retrospective cohort study.
    J Infect Dis. 2023 Apr 3:jiad090. doi: 10.1093.
    PubMed         Abstract available
    
    
22. FAUCI AS, Folkers GK
    Pandemic Preparedness and Response: Lessons From COVID-19.
    J Infect Dis. 2023;228:422-425.
    PubMed         Abstract available
    
    
23. HOEVE CE, de Gier B, Huiberts AJ, de Melker HE, et al
    Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August 2022.
    J Infect Dis. 2023 Apr 24:jiad110. doi: 10.1093.
    PubMed         Abstract available
    
    
24. YOUNG BR, Yang B, Wu P, Adam DC, et al
    Residential Clustering of Coronavirus Disease 2019 Cases and Efficiency of Building-Wide Compulsory Testing Notices as a Transmission Control Measure in Hong Kong.
    J Infect Dis. 2023;228:426-430.
    PubMed         Abstract available
    
    
25. ZAVALIS EA, Contopoulos-Ioannidis DG, Ioannidis JPA
    Transparency in Infectious Disease Research: Meta-research Survey of Specialty Journals.
    J Infect Dis. 2023;228:227-234.
    PubMed         Abstract available
    
    
26. MERENSTEIN C, Fitzgerald AS, Khatib LA, Graham-Wooten J, et al
    Effects of Mask Reuse on the Oropharyngeal, Skin, and Mask Microbiome.
    J Infect Dis. 2023;228:479-486.
    PubMed         Abstract available
    
    
27. WANG W, Goguet E, Paz Padilla S, Vassell R, et al
    Bivalent COVID-19 vaccine antibody responses to Omicron variants suggest that responses to divergent variants would be improved with matched vaccine antigens.
    J Infect Dis. 2023 Jun 6:jiad111. doi: 10.1093.
    PubMed         Abstract available
    
    
28. LEE KH, Won D, Kim J, Lee JA, et al
    Clinical Accuracy and Utility of Plasma Microbial Cell-Free DNA Whole-Genome Sequencing for the Diagnosis of Invasive Aspergillosis in Patients with Hematologic Malignancies or Coronavirus Disease 2019.
    J Infect Dis. 2023 Jun 15:jiad213. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    JAMA

29. ABBASI J
    Vigilance Urged Against Bird Flu Amid Ongoing Outbreaks in Mammals.
    JAMA. 2023;330:583-584.
    PubMed        
    
    
30. HARRIS E
    Free COVID-19 Vaccinations on the Way for Uninsured Adults.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13133.
    PubMed        
    
    
31. SURAN M
    HHS Urges Primary Care Clinicians to Help Patients Manage Long COVID's Mental Health Symptoms.
    JAMA. 2023 Jul 26. doi: 10.1001/jama.2023.13605.
    PubMed        
    
    
32. HARRIS E
    FDA Approves RSV Monoclonal Antibody for Infants and Young Children.
    JAMA. 2023;330:586.
    PubMed        
    
    
33. SELF WH, DeClercq J, Orr M
    Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    JAMA. 2023;330:664-665.
    PubMed        
    
    
34. DOS SANTOS RAS, Taccone FS, Annoni F
    Renin-Angiotensin System Modulation in Adults With COVID-19.
    JAMA. 2023;330:663-664.
    PubMed        
    
    

    
    Lancet

35. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    PubMed        
    
    
36. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

37. NAVARRETE J, Barone G, Qureshi I, Woods A, et al
    SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
    MMWR Morb Mortal Wkly Rep. 2023;72:871-876.
    PubMed         Abstract available
    
    
38. FORD ND, Slaughter D, Edwards D, Dalton A, et al
    Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1-13, 2022, to June 7-19, 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:866-870.
    PubMed         Abstract available
    
    
39. MONTOY JCC, Ford J, Yu H, Gottlieb M, et al
    Prevalence of Symptoms
    MMWR Morb Mortal Wkly Rep. 2023;72:859-865.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

40. CLAIRON Q, Prague M, Planas D, Bruel T, et al
    Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2.
    PLoS Comput Biol. 2023;19:e1011282.
    PubMed         Abstract available
    
    

    
    PLoS One

41. KEARY IP, Ravasio R, Fullarton JR, Manzoni P, et al
    A new cost-utility analysis assessing risk factor-guided prophylaxis with palivizumab for the prevention of severe respiratory syncytial virus infection in Italian infants born at 29-35 weeks' gestational age.
    PLoS One. 2023;18:e0289828.
    PubMed         Abstract available
    
    
42. WANG C, Mustafa S
    A data-driven Markov process for infectious disease transmission.
    PLoS One. 2023;18:e0289897.
    PubMed         Abstract available
    
    
43. VANSTONE M, Correia RH, Howard M, Darling E, et al
    How do perceptions of Covid-19 risk impact pregnancy-related health decisions? A convergent parallel mixed-methods study protocol.
    PLoS One. 2023;18:e0288952.
    PubMed         Abstract available
    
    
44. NEMR N, Kishk RM, Elsaid NMAB, Louis N, et al
    Knowledge, attitude, and practice (KAP) of antimicrobial prescription and its resistance among health care providers in the COVID-19 era: A cross sectional study.
    PLoS One. 2023;18:e0289711.
    PubMed         Abstract available
    
    
45. SOARES NC, Hussein A, Muhammad JS, Semreen MH, et al
    Plasma metabolomics profiling identifies new predictive biomarkers for disease severity in COVID-19 patients.
    PLoS One. 2023;18:e0289738.
    PubMed         Abstract available
    
    
46. BOTHA NN, Ansah EW, Segbedzi CE, Darkwa S, et al
    Public health concerns for food contamination in Ghana: A scoping review.
    PLoS One. 2023;18:e0288685.
    PubMed         Abstract available
    
    
47. KVALSVIG JD, Taylor M, Watt KG, Desmond C, et al
    The impact of family support and organization on adolescents during school closure under Covid-19 lockdown regulations in an area of South Africa.
    PLoS One. 2023;18:e0288501.
    PubMed         Abstract available
    
    
48. HUYNH J
    Is competition good or bad for the price, quantity, and quality of bank lending?
    PLoS One. 2023;18:e0287002.
    PubMed         Abstract available
    
    
49. ARTHUR C, Abenes K, Waselewski M, Chuisano SA, et al
    Youths' perceptions and behaviors on COVID-19 testing.
    PLoS One. 2023;18:e0290007.
    PubMed         Abstract available
    
    
50. HEENEY A, Connolly SP, Dillon R, O'Donnell A, et al
    Post-COVID care delivery: The experience from an Irish tertiary centre's post-COVID clinic.
    PLoS One. 2023;18:e0289245.
    PubMed         Abstract available
    
    
51. RABIN J, Zhao Y, Mostafa E, Al-Suqi M, et al
    Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies.
    PLoS One. 2023;18:e0288920.
    PubMed         Abstract available
    
    
52. MORENO-LOUZADA L, Menezes-Filho N
    The relationship between staying at home during the pandemic and the number of conceptions: A national panel data analysis.
    PLoS One. 2023;18:e0289604.
    PubMed         Abstract available
    
    
53. KACHIE ADT, Zhou L, Quansah PE, Xu X, et al
    Role demands and turnover intention among Covid-19 frontline nurses: The mediating and moderating roles of compassion fatigue and spiritual leadership.
    PLoS One. 2023;18:e0289888.
    PubMed         Abstract available
    
    
54. SHAYEGH S, Andreu-Perez J, Akoth C, Bosch-Capblanch X, et al
    Prioritizing COVID-19 vaccine allocation in resource poor settings: Towards an Artificial Intelligence-enabled and Geospatial-assisted decision support framework.
    PLoS One. 2023;18:e0275037.
    PubMed         Abstract available
    
    
55. KABAMI J, Owaraganise A, Beesiga B, Okiring J, et al
    Effect of the COVID-19 lockdown on the HIV care continuum in Southwestern Uganda: A time series analysis.
    PLoS One. 2023;18:e0289000.
    PubMed         Abstract available
    
    
56. WIDYASARI K, Kim S
    Efficacy of novel SARS-CoV-2 rapid antigen tests in the era of omicron outbreak.
    PLoS One. 2023;18:e0289990.
    PubMed         Abstract available
    
    
57. SCHEUNEMANN A, Kim AW, Moolla A, Subramaney U, et al
    Coping strategies employed by public psychiatric healthcare workers during the COVID-19 pandemic in southern Gauteng, South Africa.
    PLoS One. 2023;18:e0277392.
    PubMed         Abstract available
    
    
58. MOGHTADERI A, Zocchi MS, Pines JM, Venkat A, et al
    Estimating the uncertain effect of the COVID pandemic on drug overdoses.
    PLoS One. 2023;18:e0281227.
    PubMed         Abstract available
    
    
59. LORMAN V, Razzaghi H, Song X, Morse K, et al
    A machine learning-based phenotype for long COVID in children: An EHR-based study from the RECOVER program.
    PLoS One. 2023;18:e0289774.
    PubMed         Abstract available
    
    
60. UPAMALI S, Rathnayake S
    Perspectives of older people with uncontrolled type 2 diabetes mellitus towards medication adherence: A qualitative study.
    PLoS One. 2023;18:e0289834.
    PubMed         Abstract available
    
    
61. CARDONA MI, Monsees J, Schmachtenberg T, Grunewald A, et al
    Implementing a physical activity project for people with dementia in Germany-Identification of barriers and facilitator using consolidated framework for implementation research (CFIR): A qualitative study.
    PLoS One. 2023;18:e0289737.
    PubMed         Abstract available
    
    
62. WEN X, Xie W, Gao J, Zhang D, et al
    Systematically uncovering the absorbed effective substances of Radix Scutellaria-licorice drug pair in rat plasma against COVID-19 using a combined UHPLC-Q-TOF-MS analysis and target network pharmacology.
    PLoS One. 2023;18:e0289121.
    PubMed         Abstract available
    
    
63. JAMIR E, Sarma H, Priyadarsinee L, Kiewhuo K, et al
    Polypharmacology guided drug repositioning approach for SARS-CoV2.
    PLoS One. 2023;18:e0289890.
    PubMed         Abstract available
    
    
64. SEIMS AL, Hall J, Bingham DD, Creaser A, et al
    Interventions targeting children and young people's physical activity behavior at home: A systematic review.
    PLoS One. 2023;18:e0289831.
    PubMed         Abstract available
    
    
65. THORPE WJR, Gutman LM
    Trajectories of physical activity during COVID-19: A longitudinal analysis of UK young adults.
    PLoS One. 2023;18:e0289416.
    PubMed         Abstract available
    
    
66. YANG G, Zhang L
    Relationship between aging population, birth rate and disposable income per capita in the context of COVID-19.
    PLoS One. 2023;18:e0289781.
    PubMed         Abstract available
    
    
67. AHMED S, Karim A, Chowdhury TK, Pulock OS, et al
    Patients' characteristics and 30-day mortality for those undergoing elective surgeries during the COVID-19 pandemic in Bangladesh.
    PLoS One. 2023;18:e0289878.
    PubMed         Abstract available
    
    
68. HAWRYLUK I, Mishra S, Flaxman S, Bhatt S, et al
    Application of referenced thermodynamic integration to Bayesian model selection.
    PLoS One. 2023;18:e0289889.
    PubMed         Abstract available
    
    
69. KREMER P, Richter L, Melms L, Vogelmeier CF, et al
    Teaching medicine web-based with the help of interactive audience response systems.
    PLoS One. 2023;18:e0289417.
    PubMed         Abstract available
    
    
70. JATURAPISANUKUL S, Yuangtrakul N, Wangcharoenrung D, Kanchanarat K, et al
    Follow-up evaluation of pulmonary function and computed tomography findings in chronic kidney disease patients after COVID-19 infection.
    PLoS One. 2023;18:e0286832.
    PubMed         Abstract available
    
    
71. BAPAT SR, T M S
    Impact of COVID-19 lockdowns on house sparrows: Comparative study from an Indian context.
    PLoS One. 2023;18:e0289548.
    PubMed         Abstract available
    
    
72. LOCATELLI I, Rousson V
    Two complementary approaches to estimate an excess of mortality: The case of Switzerland 2022.
    PLoS One. 2023;18:e0290160.
    PubMed         Abstract available
    
    
73. WOOD AJ, Kao RR
    Empirical distributions of time intervals between COVID-19 cases and more severe outcomes in Scotland.
    PLoS One. 2023;18:e0287397.
    PubMed         Abstract available
    
    
74. SALVISBERG V, Le Vu M, Floris J, Matthes KL, et al
    Health of neonates born in the maternity hospital in Bern, Switzerland, 1880-1900 and 1914-1922.
    PLoS One. 2023;18:e0289157.
    PubMed         Abstract available
    
    
75. JANG J, Jeong H, Kim BH, An S, et al
    Vaccine effectiveness in symptom and viral load mitigation in COVID-19 breakthrough infections in South Korea.
    PLoS One. 2023;18:e0290154.
    PubMed         Abstract available
    
    
76. SHEIKH NS, Touseef M, Sultan R, Cheema KH, et al
    Understanding COVID-19 vaccine hesitancy in Pakistan: The paradigm of confidence, convenience, and complacency; A cross-sectional study.
    PLoS One. 2023;18:e0289678.
    PubMed         Abstract available
    
    
77. BRISTOW J, Hamilton J, Weinshel J, Rovig R, et al
    Interplay of demographics, geography and COVID-19 pandemic responses in the Puget Sound region: The Vashon, Washington Medical Reserve Corps experience.
    PLoS One. 2023;18:e0274345.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

78. BAILEY MJ, Currie J, Schwandt H
    The COVID-19 baby bump in the United States.
    Proc Natl Acad Sci U S A. 2023;120:e2222075120.
    PubMed         Abstract available
    
    
79. STAQUICINI DI, Cardo-Vila M, Rotolo JA, Staquicini FI, et al
    Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
    Proc Natl Acad Sci U S A. 2023;120:e2220269120.
    PubMed         Abstract available
    
    
80. WANG PY, Ma J, Kim YC, Son AY, et al
    WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.
    Proc Natl Acad Sci U S A. 2023;120:e2302738120.
    PubMed         Abstract available
    
    
81. SHEPHERD SJ, Han X, Mukalel AJ, El-Mayta R, et al
    Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines.
    Proc Natl Acad Sci U S A. 2023;120:e2303567120.
    PubMed         Abstract available
    
    
82. MANRUBIA S, Cuesta JA
    Physics of diffusion in viral genome evolution.
    Proc Natl Acad Sci U S A. 2023;120:e2310999120.
    PubMed        
    
    

    
    Vaccine

83. TAMADA Y, Takeuchi K, Kusama T, Maeda M, et al
    Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study.
    Vaccine. 2023 Jul 22:S0264-410X(23)00856-3. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
84. ROSA RG, Falavigna M, Manfio JL, de Araujo CLP, et al
    BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study.
    Vaccine. 2023 Jul 26:S0264-410X(23)00869-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
85. GREEN-MCKENZIE J, Shofer FS, Kruse G, Momplaisir F, et al
    COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact.
    Vaccine. 2023 Jul 28:S0264-410X(23)00853-8. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
86. STRUYF F, Hardt K, Van Rampelbergh R, Shukarev G, et al
    Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
    Vaccine. 2023;41:5351-5359.
    PubMed         Abstract available
    
    
87. HONDA-OKUBO Y, Bart Tarbet E, Hurst BL, Petrovsky N, et al
    An Advax-CpG adjuvanted recombinant H5 hemagglutinin vaccine protects mice against lethal influenza infection.
    Vaccine. 2023 Aug 9:S0264-410X(23)00941-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
88. BERTHELEMY C, Bouche P, Lamiral Z, Boivin JM, et al
    Parental acceptability of vaccinating young children against influenza and COVID-19.
    Vaccine. 2023 Aug 12:S0264-410X(23)00929-5. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
89. ARAUJO-CHAVERON L, Sicsic J, Moffroid H, Diaz Luevano C, et al
    Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults.
    Vaccine. 2023 Jul 20:S0264-410X(23)00805-8. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
90. PISL V, Vevera J
    COVID-19 vaccine uptake in mental healthcare users: Czech nationwide register study.
    Vaccine. 2023 Jul 19:S0264-410X(23)00840-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    
91. EMBI PJ, Levy ME, Patel P, DeSilva MB, et al
    Effectiveness of COVID-19 vaccines at preventing emergency department or urgent care encounters and hospitalizations among immunocompromised adults: An observational study of real-world data across 10 US states from August-December 2021.
    Vaccine. 2023 May 22:S0264-410X(23)00588-1. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available
    
    

    
    Virology

92. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
    H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
    Virology. 2023;587:109860.
    PubMed         Abstract available
    
    

    
    Virus Res

93. LEE MM, Cho WK, Cha MH, Yim NH, et al
    The antiviral activity of Thuja orientalis folium against Influenza A virus.
    Virus Res. 2023 Aug 13:199199. doi: 10.1016/j.virusres.2023.199199.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: